MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/tcrm.s154720

Медицинская библиотека · Therapeutics and clinical risk management · 2018

Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries.

Saunders Rhodri, Davis Jason A, Kranke Peter, Weissbrod Rachel, Whitaker David K, Lightdale Jenifer R

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Studies have reported on the incidence of sedation-related adverse events (AEs), but little is known about their impact on health care costs and resource use.

METHODS

Health care providers and payers in five countries were recruited for an online survey by independent administrators to ensure that investigators and respondents were blinded to each other. Surveys were conducted in the local language and began with a "screener" to ensure that respondents had relevant expertise and experience. Responses were analyzed using Excel and R, with the Dixon's Q statistic used to identify and remove outliers. Global and country-specific average treatment patterns were calculated via bootstrapping; costs were mean values. The sum product of costs and intervention probability gave a cost per AE.

RESULTS

Responses were received from 101 providers and 26 payers, the majority having >5 years of experience. At a minimum, the respondents performed a total of 3,430 procedural sedations per month. All AEs detailed occurred in clinical practice in the last year and were reported to cause procedural delays and cancellations in some patients. Standard procedural sedation costs ranged from €74 (Germany) to $2,300 (US). Respondents estimated that AEs would increase costs by between 16% (Italy) and 179% (US). Hypotension was reported as the most commonly observed AE with an associated global mean cost (interquartile range) of $43 ($27-$68). Other frequent AEs, including mild hypotension, bradycardia, tachycardia, mild oxygen desaturation, hypertension, and brief apnea, were estimated to increase health care spending on procedural sedation by $2.2 billion annually in the US.

CONCLUSION

All sedation-related AEs can increase health care costs and result in substantial delays or cancellations of subsequent procedures. The prevention of even minor AEs during procedural sedation may be crucial to ensuring its value as a health care service.

Для цитирования: Saunders Rhodri, Davis Jason A, Kranke Peter, Weissbrod Rachel, Whitaker David K, Lightdale Jenifer R. Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries.. Therapeutics and clinical risk management. 2018. DOI: 10.2147/tcrm.s154720.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.